Southeast Asset Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Southeast Asset Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,422	Closed	-$36K	–	94
2015 Q1	$36K	Buy	+5,422	New	+$37K	0.01%	86
2013 Q4	–	Sell	-9,508	Closed	-$158K	–	103
2013 Q3	$158K	Hold	9,508	–	–	0.07%	93
2013 Q2	$144K	Buy	+9,508	New	+$144K	0.07%	83

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Southeast Asset Advisors's LXRX Position: Q2 2015 in Review

Southeast Asset Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 5,422 shares — an estimated $36K sold.

Southeast Asset Advisors first reported a position in LXRX in Q2 2013 and held it in 3 quarters. The position peaked at $158K in Q3 2013. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

Southeast Asset Advisors reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Southeast Asset Advisors sold 5,422 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $36K.
Southeast Asset Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 3 quarters.
Southeast Asset Advisors's Lexicon Pharmaceuticals position peaked at $158K in Q3 2013.
94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on Southeast Asset Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.